ask="1.68"
ask_size="200"
average_daily_volume="87897"
bid="1.56"
bid_size="2000"
book_value="0.39"
change="+0.21"
change_from_200_day_moving_average="0.17"
change_from_50_day_moving_average="0.05"
change_from_52_week_high="-0.30"
change_From_52_week_low="0.93"
change_in_percent="+14.29%"
close="1.68"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.25"
ebitda="-12.06M"
eps_estimate_current_year="-0.14"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.08"
ex_dividend_date="6/24/2005"
float_shares="35315000"
high="1.84"
high_52_weeks="1.98"
last_trade_date="1/23/2017"
last_trade_price="1.68"
last_trade_size="400"
last_trade_time="4:00pm"
low="1.56"
low_52_weeks="0.75"
market_capitalization="113.51M"
moving_average_200_day="1.51"
moving_average_50_day="1.63"
name="Biolase
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.75"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+11.09%"
percent_change_from_50_day_moving_average="+3.09%"
percent_change_from_52_week_high="-15.15%"
percent_change_from_52_week_low="+124.00%"
previous_close="1.47"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.81"
price_per_sales="1.89"
revenue="52.44M"
shares_outstanding="67565000"
short_ratio="26.20"
stock_exchange="NCM"
symbol="BIOL"
volume="3860675"
weeks_range_52="0.75 - 1.98"
